312 related articles for article (PubMed ID: 28915465)
1. Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer's disease: A review.
Jiang Y; Gao H; Turdu G
Bioorg Chem; 2017 Dec; 75():50-61. PubMed ID: 28915465
[TBL] [Abstract][Full Text] [Related]
2. Extracts from Traditional Chinese Medicinal Plants Inhibit Acetylcholinesterase, a Known Alzheimer's Disease Target.
Kaufmann D; Kaur Dogra A; Tahrani A; Herrmann F; Wink M
Molecules; 2016 Aug; 21(9):. PubMed ID: 27589716
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Inhibition of Acetylcholinesterase by Alkaloids Derived from Stephaniae Tetrandrae Radix, Coptidis Rhizoma and Phellodendri Chinensis Cortex.
Kong XP; Liu EYL; Chen ZC; Xu ML; Yu AXD; Wu QY; Xia YJ; Duan R; Dong TTX; Tsim KWK
Molecules; 2019 Dec; 24(24):. PubMed ID: 31847089
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Effects of Active Components of Chinese Herbal Medicine in the Treatment of Alzheimer's Disease: A Review.
Wang ZY; Liu JG; Li H; Yang HM
Am J Chin Med; 2016; 44(8):1525-1541. PubMed ID: 27848250
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Acetylcholinesterase (AChE): A Potential Therapeutic Target to Treat Alzheimer's Disease.
Li Y; Zhang XX; Jiang LJ; Yuan L; Cao TT; Li X; Dong L; Li Y; Yin SF
Chem Biol Drug Des; 2015 Oct; 86(4):776-82. PubMed ID: 25736722
[TBL] [Abstract][Full Text] [Related]
6. Anti-acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer's disease.
Lin HQ; Ho MT; Lau LS; Wong KK; Shaw PC; Wan DC
Chem Biol Interact; 2008 Sep; 175(1-3):352-4. PubMed ID: 18573242
[TBL] [Abstract][Full Text] [Related]
7. Computational pharmaceutical analysis of anti-Alzheimer's Chinese medicine Coptidis Rhizoma alkaloids.
Hong HJ; Chen PY; Shih TC; Ou CY; Jhuo MD; Huang YY; Cheng CH; Wu YC; Chung JG
Mol Med Rep; 2012 Jan; 5(1):142-7. PubMed ID: 22002431
[TBL] [Abstract][Full Text] [Related]
8. Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro.
Guo AJ; Xie HQ; Choi RC; Zheng KY; Bi CW; Xu SL; Dong TT; Tsim KW
Chem Biol Interact; 2010 Sep; 187(1-3):246-8. PubMed ID: 20452337
[TBL] [Abstract][Full Text] [Related]
9. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous screening, identification, quantitation, and activity evaluation of six acetylcholinesterase (AChE) inhibitors in Coptidis Rhizoma by online UPLC-DAD coupled with AChE biochemical detection.
Tan JL; Xu YL; Fei YQ; Zheng GH; Ding XP
J Pharm Biomed Anal; 2022 Sep; 219():114897. PubMed ID: 35780528
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore-based drug design for potential AChE inhibitors from Traditional Chinese Medicine Database.
Jiang Y; Gao H
Bioorg Chem; 2018 Feb; 76():400-414. PubMed ID: 29258018
[TBL] [Abstract][Full Text] [Related]
12. Anti-Alzheimer's disease potential of traditional chinese medicinal herbs as inhibitors of BACE1 and AChE enzymes.
Dai R; Sun Y; Su R; Gao H
Biomed Pharmacother; 2022 Oct; 154():113576. PubMed ID: 36007279
[TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibition on acetylcholinesterase by the combination of berberine and palmatine originally isolated from Chinese medicinal herbs.
Mak S; Luk WW; Cui W; Hu S; Tsim KW; Han Y
J Mol Neurosci; 2014 Jul; 53(3):511-6. PubMed ID: 24793543
[TBL] [Abstract][Full Text] [Related]
14. Design of Curcumin and Flavonoid Derivatives with Acetylcholinesterase and Beta-Secretase Inhibitory Activities Using in Silico Approaches.
Tran TS; Le MT; Tran TD; Tran TH; Thai KM
Molecules; 2020 Aug; 25(16):. PubMed ID: 32785161
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
Li RS; Wang XB; Hu XJ; Kong LY
Bioorg Med Chem Lett; 2013 May; 23(9):2636-41. PubMed ID: 23511019
[TBL] [Abstract][Full Text] [Related]
16. Natural products as sources of new lead compounds for the treatment of Alzheimer's disease.
Huang L; Su T; Li X
Curr Top Med Chem; 2013; 13(15):1864-78. PubMed ID: 23931437
[TBL] [Abstract][Full Text] [Related]
17. Exploring Medicinal Herbs' Therapeutic Potential and Molecular Docking Analysis for Compounds as Potential Inhibitors of Human Acetylcholinesterase in Alzheimer's Disease Treatment.
Farihi A; Bouhrim M; Chigr F; Elbouzidi A; Bencheikh N; Zrouri H; Nasr FA; Parvez MK; Alahdab A; Ahami AOT
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893530
[No Abstract] [Full Text] [Related]
18. Potent Acetylcholinesterase Inhibitors: Potential Drugs for Alzheimer's Disease.
Akıncıoğlu H; Gülçin İ
Mini Rev Med Chem; 2020; 20(8):703-715. PubMed ID: 31902355
[TBL] [Abstract][Full Text] [Related]
19. Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs.
Lazarevic-Pasti T; Leskovac A; Momic T; Petrovic S; Vasic V
Curr Med Chem; 2017; 24(30):3283-3309. PubMed ID: 28685687
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer's disease.
Kim MH; Kim SH; Yang WM
Planta Med; 2014 Oct; 80(15):1249-58. PubMed ID: 25210998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
